{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T22:32:40Z","timestamp":1793053960732,"version":"4.5.0"},"reference-count":134,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,2,4]],"date-time":"2025-02-04T00:00:00Z","timestamp":1738627200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"abstract":"<jats:p>Alzheimer\u2019s disease (AD) is the most common cause of dementia and represents 75% of all dementia types. AD neuropathology is due to the progressive deposition of extracellular amyloid-beta (A<jats:italic>\u03b2<\/jats:italic>) peptide and intracellular hyperphosphorylated tau protein. The accumulated A\u03b2 forms amyloid plaques, while the hyperphosphorylated tau protein forms neurofibrillary tangles (NFTs). Both amyloid plaques and NFTs are hallmarks of AD neuropathology. The fundamental mechanism involved in the pathogenesis of AD is still elusive, although A\u03b2 is the more conceivable theory. A\u03b2-induced neurodegeneration and associated neuroinflammation, oxidative stress, endoplasmic reticulum stress (ER), and mitochondrial dysfunction contribute to the development of cognitive impairment and dementia. Of note, A\u03b2 is not only originated from the brain but also produced peripherally and, via the blood\u2013brain barrier (BBB), can accumulate in the brain and result in the development of AD. It has been shown that cardiometabolic conditions such as obesity, type 2 diabetes (T2D), and heart failure (HF) are regarded as possible risk factors for the development of AD and other types of dementia, such as vascular dementia. HF-induced chronic cerebral hypoperfusion, oxidative stress, and inflammation can induce the development and progression of AD. Interestingly, AD is regarded as a systemic disease that causes systemic inflammation and oxidative stress, which in turn affects peripheral organs, including the heart. A\u03b2 through deranged BBB can be transported into the systemic circulation from the brain and accumulated in the heart, leading to the development of HF. These findings suggest a close relationship between AD and HF. However, the exact mechanism of AD-induced HF is not fully elucidated. Therefore, this review aims to discuss the link between AD and the risk of HF regarding the potential role of A\u03b2 in the pathogenesis of HF.<\/jats:p>","DOI":"10.3389\/fmed.2025.1494101","type":"journal-article","created":{"date-parts":[[2025,2,4]],"date-time":"2025-02-04T06:34:57Z","timestamp":1738650897000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":42,"title":["Amyloid-\u03b2 and heart failure in Alzheimer\u2019s disease: the new vistas"],"prefix":"10.3389","volume":"12","author":[{"given":"Hayder M.","family":"Al-Kuraishy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ghassan M.","family":"Sulaiman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hamdoon A.","family":"Mohammed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sohaib G.","family":"Mohammed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali I.","family":"Al-Gareeb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali K.","family":"Albuhadily","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Retaj A.","family":"Dawood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amer","family":"Al Ali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammed H.","family":"Abu-Alghayth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,2,4]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"102084","DOI":"10.1016\/j.arr.2023.102084","article-title":"The link between Alzheimer disease and metabolic syndrome: a mutual relationship and long rigorous investigation","volume":"91","author":"Al-Kuraishy","year":"2023","journal-title":"Ageing Res Rev"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/pharmaceutics14010001","article-title":"Natural polysaccharides as preventive and therapeutic horizon for neurodegenerative diseases","volume":"14","author":"Dhahri","year":"2021","journal-title":"Pharmaceutics"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/j.jalz.2012.02.001","article-title":"2012 Alzheimer\u2019s disease facts and figures","volume":"8","year":"2012","journal-title":"Alzheimers Dement"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1016\/j.ijbiomac.2020.11.192","article-title":"Review on Alzheimer\u2019s disease: inhibition of amyloid beta and tau tangle formation","volume":"167","author":"Ashrafian","year":"2021","journal-title":"Int J Biol Macromol"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"2181","DOI":"10.7150\/ijbs.57078","article-title":"Interaction between A\u03b2 and tau in the pathogenesis of Alzheimer\u2019s disease","volume":"17","author":"Zhang","year":"2021","journal-title":"Int J Biol Sci"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1152\/physrev.00030.2022","article-title":"Oxidative damage in neurodegeneration: roles in the pathogenesis and progression of Alzheimer disease","volume":"104","author":"Perluigi","year":"2024","journal-title":"Physiol Rev"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"742408","DOI":"10.3389\/fnagi.2022.742408","article-title":"Alzheimer\u2019s disease: an update and insights into pathophysiology","volume":"14","author":"Abubakar","year":"2022","journal-title":"Front Aging Neurosci"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"102233","DOI":"10.1016\/j.arr.2024.102233","article-title":"Role of ketogenic diet in neurodegenerative diseases focusing on Alzheimer diseases: the guardian angle","volume":"95","author":"al-kuraishy","year":"2024","journal-title":"Ageing Res Rev"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"102119","DOI":"10.1016\/j.arr.2023.102119","article-title":"Evaluation and targeting of amyloid precursor protein (APP)\/amyloid beta (A\u03b2) axis in amyloidogenic and non-amyloidogenic pathways: a time outside the tunnel","volume":"92","author":"al-kuraishy","year":"2023","journal-title":"Ageing Res Rev"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"1422912","DOI":"10.3389\/fnins.2024.1422912","article-title":"The role of statins in amyotrophic lateral sclerosis: protective or not?","volume":"18","author":"al-Kuraishy","year":"2024","journal-title":"Front Neurosci"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1007\/s13760-023-02403-x","article-title":"The probable role of tissue plasminogen activator\/neuroserpin axis in Alzheimer\u2019s disease: a new perspective","volume":"124","author":"Ali","year":"2024","journal-title":"Acta Neurol Belg"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13195-021-00935-z","article-title":"Intermittent hypoxia treatment alleviates memory impairment in the 6-month-old APPswe\/PS1dE9 mice and reduces amyloid beta accumulation and inflammation in the brain","volume":"13","author":"Yue","year":"2021","journal-title":"Alzheimers Res Ther"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"1012779","DOI":"10.3389\/fnagi.2022.1012779","article-title":"Ischemia as a common trigger for Alzheimer\u2019s disease","volume":"14","author":"Elman-Shina","year":"2022","journal-title":"Front Aging Neurosci"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"313","DOI":"10.14283\/jpad.2021.15","article-title":"The epidemiology of Alzheimer\u2019s disease modifiable risk factors and prevention","volume":"8","author":"Zhang","year":"2021","journal-title":"J Prev Alzheimers Dis"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"768 at","DOI":"10.3389\/fnins.2019.00768","article-title":"The Alzheimer\u2019s disease challenge","volume":"13","author":"Alexiou","year":"2019","journal-title":"Front Neurosci"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"383","DOI":"10.3389\/fnins.2018.00383","article-title":"Alzheimer\u2019s disease and type 2 diabetes: a critical assessment of the shared pathological traits","volume":"12","author":"Chatterjee","year":"2018","journal-title":"Front Neurosci"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"2186","DOI":"10.1093\/brain\/awab099","article-title":"Comorbid neuropathological diagnoses in early versus late-onset Alzheimer\u2019s disease","volume":"144","author":"Spina","year":"2021","journal-title":"Brain"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"834661","DOI":"10.3389\/fcell.2022.834661","article-title":"Early-life environment influence on late-onset Alzheimer\u2019s disease","volume":"10","author":"Gauvrit","year":"2022","journal-title":"Front Cell Dev Biol"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"789099","DOI":"10.3389\/fnagi.2021.789099","article-title":"Radiomic features of the hippocampus for diagnosing early-onset and late-onset Alzheimer\u2019s disease","volume":"13","author":"du","year":"2022","journal-title":"Front Aging Neurosci"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"381","DOI":"10.3233\/ADR-220108","article-title":"Common signaling pathways involved in Alzheimer\u2019s disease and stroke: two faces of the same coin","volume":"7","author":"Das","year":"2023","journal-title":"J Alzheimers Dis Rep"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"e89","DOI":"10.2337\/dc22-1952","article-title":"Endoscopic duodenal-jejunal bypass liner treatment for type 2 diabetes and obesity: glycemic and cardiovascular disease risk factor improvements in 1,022 patients treated worldwide","volume":"46","author":"Ryder","year":"2023","journal-title":"Diabetes Care"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1038\/nrneurol.2017.111","article-title":"A systemic view of Alzheimer disease\u2014insights from amyloid-\u03b2 metabolism beyond the brain","volume":"13","author":"Wang","year":"2017","journal-title":"Nat Rev Neurol"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s40035-020-00195-1","article-title":"Peripheral clearance of brain-derived A\u03b2 in Alzheimer\u2019s disease: pathophysiology and therapeutic perspectives","volume":"9","author":"Cheng","year":"2020","journal-title":"Transl Neurodegener"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1007\/s10741-021-10114-9","article-title":"Is heart failure with preserved ejection fraction a \u2018dementia\u2019of the heart?","volume":"27","author":"Tini","year":"2022","journal-title":"Heart Fail Rev"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1146\/annurev-med-052918-020140","article-title":"Cardiac amyloidosis: overlooked, underappreciated, and treatable","volume":"71","author":"Rubin","year":"2020","journal-title":"Annu Rev Med"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"263","DOI":"10.21037\/cdt-20-302","article-title":"Pathophysiology of heart failure","volume":"11","author":"Schwinger","year":"2021","journal-title":"Cardiovasc Diagn Ther"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1002\/ejhf.2115","article-title":"Universal definition and classification of heart failure: a report of the heart failure society of America, heart failure association of the European society of cardiology, Japanese heart failure society and writing committee of the universal definition of heart failure","volume":"27","author":"Bozkurt","year":"2021","journal-title":"J Card Fail"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"3217","DOI":"10.1016\/j.jacc.2021.04.070","article-title":"Classification of heart failure according to ejection fraction: JACC review topic of the week","volume":"77","author":"Lam","year":"2021","journal-title":"J Am Coll Cardiol"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1007\/s11897-021-00533-y","article-title":"Heart failure with reduced ejection fraction\u2014does sex matter? Curr","volume":"18","author":"Swaraj","year":"2021","journal-title":"Heart Fail Rep"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"mjac028","DOI":"10.1093\/jmcb\/mjac028","article-title":"Heart failure with preserved ejection fraction (HFpEF) in type 2 diabetes mellitus: from pathophysiology to therapeutics","volume":"14","author":"Abudureyimu","year":"2022","journal-title":"J Mol Cell Biol"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1016\/j.hfc.2021.02.001","article-title":"Pathophysiology of heart failure with preserved ejection fraction","volume":"17","author":"Youn","year":"2021","journal-title":"Heart Fail Clin"},{"key":"ref32","doi-asserted-by":"publisher","first-page":"1541","DOI":"10.21037\/cdt-20-477","article-title":"Left ventricular dysfunction in heart failure with preserved ejection fraction\u2014molecular mechanisms and impact on right ventricular function","volume":"10","author":"Heinzel","year":"2020","journal-title":"Cardiovasc Diagn Ther"},{"key":"ref33","doi-asserted-by":"publisher","first-page":"242","DOI":"10.3390\/cells9010242","article-title":"Cellular and molecular differences between HFpEF and HFrEF: a step ahead in an improved pathological understanding","volume":"9","author":"Simmonds","year":"2020","journal-title":"Cells"},{"key":"ref34","doi-asserted-by":"publisher","first-page":"e254","DOI":"10.1161\/CIR.0000000000000950","article-title":"On behalf of the American Heart Association Council on epidemiology and prevention statistics committee and stroke statistics subcommittee heart disease and stroke statistics-2021 update: a report from the American Heart Association","volume":"143","author":"Virani","year":"2021","journal-title":"Circulation"},{"key":"ref35","doi-asserted-by":"publisher","first-page":"1789","DOI":"10.1016\/S0140-6736(18)32279-7","article-title":"Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990\u20132017: A systematic analysis for the global burden of disease study 2017","volume":"392","year":"2018","journal-title":"Lancet"},{"key":"ref36","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.1136\/hrt.2003.025270","article-title":"Clinical epidemiology of heart failure","volume":"93","author":"Mosterd","year":"2007","journal-title":"Heart"},{"key":"ref37","doi-asserted-by":"publisher","first-page":"e153","DOI":"10.1161\/CIR.0000000000001052","article-title":"Heart disease and stroke statistics\u20142022 update: a report from the American Heart Association","volume":"145","author":"Tsao","year":"2022","journal-title":"Circulation"},{"key":"ref38","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1038\/nrcardio.2010.165","article-title":"Epidemiology and risk profile of heart failure","volume":"8","author":"Bui","year":"2011","journal-title":"Nat Rev Cardiol"},{"key":"ref39","doi-asserted-by":"publisher","first-page":"272","DOI":"10.31083\/j.rcm2508272","article-title":"Load dependency of ventricular pump function: impact on the non-invasive evaluation of the severity and the prognostic relevance of myocardial dysfunction","volume":"25","author":"Dandel","year":"2024","journal-title":"Rev Cardiovasc Med"},{"key":"ref40","doi-asserted-by":"publisher","first-page":"6201","DOI":"10.3390\/ijms24076201","article-title":"Hypoxia-inducible factor 1-alpha and glucose metabolism during cardiac remodeling progression from hypertrophy to heart failure","volume":"24","author":"Sant\u2019Ana","year":"2023","journal-title":"Int J Mol Sci"},{"key":"ref41","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1016\/j.amsu.2022.103501","article-title":"Doxorubicin induced immune abnormalities and inflammatory responses via HMGB1, HIF1-\u03b1 and VEGF pathway in progressive of cardiovascular damage","volume":"76","author":"Syukri","year":"2022","journal-title":"Ann Med Surg"},{"key":"ref42","doi-asserted-by":"publisher","first-page":"2001","DOI":"10.3390\/cells13232001","article-title":"Pathophysiology of angiotensin II-mediated hypertension, cardiac hypertrophy, and failure: a perspective from macrophages","volume":"13","author":"Carter","year":"2024","journal-title":"Cells"},{"key":"ref43","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1016\/S0140-6736(81)91063-1","article-title":"Cardiogenic dementia\u2014a myth?","volume":"318","author":"Emerson","year":"1981","journal-title":"Lancet"},{"key":"ref44","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1097\/01.JCN.0000305096.09710.ec","article-title":"Cognitive functioning and chronic heart failure: a review of the literature (2002-July 2007)","volume":"23","author":"Pressler","year":"2008","journal-title":"J Cardiovasc Nurs"},{"key":"ref45","doi-asserted-by":"publisher","first-page":"1764","DOI":"10.1111\/j.1532-5415.2007.01395.x","article-title":"Profile of cognitive impairment in chronic heart failure","volume":"55","author":"Vogels","year":"2007","journal-title":"J Am Geriatr Soc"},{"key":"ref46","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1093\/eurjhf\/hft020","article-title":"Cognitive impairment in heart failure: results from the trial of intensified versus standard medical therapy in elderly patients with congestive heart failure (TIME-CHF) randomized trial","volume":"15","author":"Huijts","year":"2013","journal-title":"Eur J Heart Fail"},{"key":"ref47","doi-asserted-by":"publisher","first-page":"1986","DOI":"10.1212\/WNL.57.11.1986","article-title":"Hypotension and cognitive impairment","volume":"57","author":"Zuccal\u00e0","year":"2001","journal-title":"Neurology"},{"key":"ref48","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1136\/jnnp-2014-309968","article-title":"The N-terminal pro B-type natriuretic peptide, and risk of dementia and cognitive decline: a 10-year follow-up study in the general population","volume":"87","author":"Mirza","year":"2016","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"ref49","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1212\/WNL.0000000000001885","article-title":"N-terminal pro\u2013brain natriuretic peptide and abnormal brain aging: the AGES\u2013Reykjavik study","volume":"85","author":"Sabayan","year":"2015","journal-title":"Neurology"},{"key":"ref50","doi-asserted-by":"publisher","first-page":"9660","DOI":"10.1007\/s11357-014-9660-1","article-title":"Plasma NT-proBNP as predictor of change in functional status, cardiovascular morbidity and mortality in the oldest old: the Leiden 85-plus study","volume":"36","author":"van Peet","year":"2014","journal-title":"Age (Dordr)"},{"key":"ref51","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1111\/joim.12287","article-title":"Heart failure and Alzheimer\u2019s disease","volume":"277","author":"Cermakova","year":"2015","journal-title":"J Intern Med"},{"key":"ref52","doi-asserted-by":"publisher","first-page":"3446","DOI":"10.1007\/s11064-017-2391-9","article-title":"Chronic cerebral Hypoperfusion promotes amyloid-Beta pathogenesis via activating \u03b2\/\u03b3-secretases","volume":"42","author":"Cai","year":"2017","journal-title":"Neurochem Res"},{"key":"ref53","doi-asserted-by":"publisher","first-page":"680","DOI":"10.1134\/S0006297921060067","article-title":"Effect of global brain ischemia on amyloid precursor protein metabolism and expression of amyloid-degrading enzymes in rat cortex: role in pathogenesis of Alzheimer\u2019s disease","volume":"86","author":"Babusikova","year":"2021","journal-title":"Biochemistry (Mosc)"},{"key":"ref54","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1007\/s10571-014-0127-9","article-title":"From chronic cerebral hypoperfusion to Alzheimer-like brain pathology and neurodegeneration","volume":"35","author":"Zhao","year":"2015","journal-title":"Cell Mol Neurobiol"},{"key":"ref55","doi-asserted-by":"publisher","first-page":"107213","DOI":"10.1016\/j.vph.2023.107213","article-title":"Amyloid-\u03b2: a potential mediator of aging-related vascular pathologies","volume":"152","author":"Khan","year":"2023","journal-title":"Vasc Pharmacol"},{"key":"ref56","doi-asserted-by":"publisher","first-page":"4899688","DOI":"10.1155\/2021\/4899688","article-title":"Cognitive dysfunction after heart disease: a manifestation of the heart-brain Axis","volume":"2021","author":"Xu","year":"2021","journal-title":"Oxidative Med Cell Longev"},{"key":"ref57","doi-asserted-by":"publisher","first-page":"8035","DOI":"10.1007\/s12035-019-01655-0","article-title":"Neurocognitive disorders in heart failure: novel pathophysiological mechanisms underpinning memory loss and learning impairment","volume":"56","author":"Toledo","year":"2019","journal-title":"Mol Neurobiol"},{"key":"ref58","doi-asserted-by":"publisher","first-page":"e63829","DOI":"10.1371\/journal.pone.0063829","article-title":"Increases in the risk of cognitive impairment and alterations of cerebral \u03b2-amyloid metabolism in mouse model of heart failure","volume":"8","author":"Hong","year":"2013","journal-title":"PLoS One"},{"key":"ref59","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1016\/j.pbb.2014.09.005","article-title":"Protective role of luteolin against cognitive dysfunction induced by chronic cerebral hypoperfusion in rats","volume":"126","author":"Fu","year":"2014","journal-title":"Pharmacol Biochem Behav"},{"key":"ref60","doi-asserted-by":"publisher","first-page":"e02176","DOI":"10.1002\/brb3.2176","article-title":"Cerebral blood flow impairment and cognitive decline in heart failure","volume":"11","author":"Ovsenik","year":"2021","journal-title":"Brain Behav"},{"key":"ref61","doi-asserted-by":"publisher","first-page":"831734","DOI":"10.3389\/fcvm.2021.831734","article-title":"Cognitive impairment in heart failure: landscape, challenges, and future directions","volume":"8","author":"Yang","year":"2021","journal-title":"Front Cardiovasc Med"},{"key":"ref62","doi-asserted-by":"publisher","first-page":"102","DOI":"10.3390\/antiox11010102","article-title":"A leaky blood-brain barrier to fibrinogen contributes to oxidative damage in Alzheimer\u2019s disease","volume":"11","author":"McLarnon","year":"2021","journal-title":"Antioxidants (Basel, Switzerland)"},{"key":"ref63","doi-asserted-by":"publisher","first-page":"311","DOI":"10.3390\/ijms232113311","article-title":"Stellate ganglia and cardiac sympathetic Overactivation in heart failure","volume":"23","author":"Li","year":"2022","journal-title":"Int J Mol Sci"},{"key":"ref64","doi-asserted-by":"publisher","first-page":"101622","DOI":"10.1016\/j.arr.2022.101622","article-title":"Glial cells in Alzheimer\u2019s disease: from neuropathological changes to therapeutic implications","volume":"78","author":"Uddin","year":"2022","journal-title":"Ageing Res Rev"},{"key":"ref65","doi-asserted-by":"publisher","first-page":"129\u2013131 at","DOI":"10.1016\/j.jchf.2018.12.014","article-title":"Amyloidosis of the brain and heart: two sides of the same coin? JACC","volume":"7","author":"Schaich","year":"2019","journal-title":"Heart Failure"},{"key":"ref66","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1161\/CIRCULATIONAHA.109.905091","article-title":"Cardiac index is associated with brain aging: the Framingham heart study","volume":"122","author":"Jefferson","year":"2010","journal-title":"Circulation"},{"key":"ref67","doi-asserted-by":"publisher","first-page":"2395","DOI":"10.1016\/j.jacc.2016.08.073","article-title":"A\u03b2 amyloid pathology affects the hearts of patients with Alzheimer\u2019s disease: mind the heart","volume":"68","author":"Troncone","year":"2016","journal-title":"J Am Coll Cardiol"},{"key":"ref68","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.jchf.2022.09.006","article-title":"Plasma amyloid-\u03b2 in relation to cardiac function and risk of heart failure in general population","volume":"11","author":"Zhu","year":"2023","journal-title":"JACC Heart Fail"},{"key":"ref69","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.2147\/CIA.S63337","article-title":"Altered diastolic function and aortic stiffness in Alzheimer\u2019s disease","volume":"9","author":"\u00c7al\u0131k","year":"2014","journal-title":"Clin Interv Aging"},{"key":"ref70","doi-asserted-by":"publisher","first-page":"919","DOI":"10.3233\/JAD-170088","article-title":"Reduced cardiovascular functions in patients with Alzheimer\u2019s disease","volume":"58","author":"Jin","year":"2017","journal-title":"J Alzheimers Dis"},{"key":"ref71","doi-asserted-by":"publisher","first-page":"483","DOI":"10.3233\/JAD-2011-110866","article-title":"Reduced mitochondria cytochrome oxidase activity in adult children of mothers with Alzheimer\u2019s disease","volume":"27","author":"Mosconi","year":"2011","journal-title":"J Alzheimers Dis"},{"key":"ref72","doi-asserted-by":"publisher","first-page":"1340","DOI":"10.1016\/j.bbadis.2014.04.012","article-title":"Is Alzheimer\u2019s disease a systemic disease?","volume":"1842","author":"Morris","year":"2014","journal-title":"Biochim Biophys Acta"},{"key":"ref73","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1056\/NEJMra1106180","article-title":"Proteotoxicity and cardiac dysfunction\u2014Alzheimer\u2019s disease of the heart?","volume":"368","author":"Willis","year":"2013","journal-title":"N Engl J Med"},{"key":"ref74","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1016\/j.jacc.2014.12.035","article-title":"Amyloid-beta (1-40) and the risk of death from cardiovascular causes in patients with coronary heart disease","volume":"65","author":"Stamatelopoulos","year":"2015","journal-title":"J Am Coll Cardiol"},{"key":"ref75","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1016\/S0002-9440(10)64947-4","article-title":"Elevated A\u03b242 in skeletal muscle of Alzheimer disease patients suggests peripheral alterations of A\u03b2PP metabolism","volume":"156","author":"Kuo","year":"2000","journal-title":"Am J Pathol"},{"key":"ref76","doi-asserted-by":"publisher","first-page":"25","DOI":"10.3389\/fcvm.2015.00025","article-title":"Functional amyloid signaling via the inflammasome, necrosome, and signalosome: new therapeutic targets in heart failure","volume":"2","author":"Parry","year":"2015","journal-title":"Front. Cardiovasc. Med."},{"key":"ref77","doi-asserted-by":"publisher","first-page":"1030","DOI":"10.1086\/509900","article-title":"Mutations of presenilin genes in dilated cardiomyopathy and heart failure","volume":"79","author":"Li","year":"2006","journal-title":"Am J Hum Genet"},{"key":"ref78","doi-asserted-by":"publisher","first-page":"1548","DOI":"10.1002\/jcp.26057","article-title":"Conditionally targeted deletion of PSEN1 leads to diastolic heart dysfunction","volume":"233","author":"Song","year":"2018","journal-title":"J Cell Physiol"},{"key":"ref79","doi-asserted-by":"publisher","first-page":"8417","DOI":"10.3390\/ijms24098417","article-title":"Presenilin-1 (PSEN1) mutations: clinical phenotypes beyond Alzheimer\u2019s disease","volume":"24","author":"Yang","year":"2023","journal-title":"Int J Mol Sci"},{"key":"ref80","doi-asserted-by":"publisher","first-page":"100857","DOI":"10.1016\/j.yfrne.2020.100857","article-title":"Blood-brain barrier integrity in the pathogenesis of Alzheimer\u2019s disease","volume":"59","author":"Huang","year":"2020","journal-title":"Front Neuroendocrinol"},{"key":"ref81","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1136\/jnnp-2021-327864","article-title":"Plasma A\u03b2 as a biomarker for predicting A\u03b2-PET status in Alzheimer\u2019s disease: a systematic review with meta-analysis","volume":"93","author":"Cheng","year":"2022","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"ref82","doi-asserted-by":"publisher","first-page":"365","DOI":"10.3233\/JAD-2011-101977","article-title":"Meta-analysis of plasma amyloid-\u03b2 levels in Alzheimer\u2019s disease","volume":"26","author":"Song","year":"2011","journal-title":"J Alzheimers Dis"},{"key":"ref83","doi-asserted-by":"publisher","first-page":"116974","DOI":"10.1016\/j.jns.2020.116974","article-title":"Revisiting the role of brain and peripheral A\u03b2 in the pathogenesis of Alzheimer\u2019s disease","volume":"416","author":"Uddin","year":"2020","journal-title":"J Neurol Sci"},{"key":"ref84","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s11886-020-01318-w","article-title":"Heart and brain: complex relationships for left ventricular dysfunction","volume":"22","author":"Daniele","year":"2020","journal-title":"Curr Cardiol Rep"},{"key":"ref85","doi-asserted-by":"publisher","first-page":"11993","DOI":"10.1073\/pnas.91.25.11993","article-title":"Excessive production of amyloid beta-protein by peripheral cells of symptomatic and presymptomatic patients carrying the Swedish familial Alzheimer disease mutation","volume":"91","author":"Citron","year":"1994","journal-title":"Proc Natl Acad Sci"},{"key":"ref86","doi-asserted-by":"publisher","first-page":"P1296","DOI":"10.1016\/j.jalz.2018.06.1829","article-title":"P3-465: increase in aortic stiffness and development of cardiac hypertrophy is associated with cognitive impairment in 2XTG-ad mice","volume":"14","author":"Grigorova","year":"2018","journal-title":"Alzheimers Dement"},{"key":"ref87","doi-asserted-by":"publisher","first-page":"1262","DOI":"10.4103\/1673-5374.386406","article-title":"Amyloid-beta and tau protein beyond Alzheimer\u2019s disease","volume":"19","author":"Abyadeh","year":"2024","journal-title":"Neural Regen Res"},{"key":"ref88","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1080\/10408363.2019.1678011","article-title":"Detection of amyloid beta peptides in body fluids for the diagnosis of alzheimer\u2019s disease: where do we stand?","volume":"57","author":"Veerabhadrappa","year":"2020","journal-title":"Crit Rev Clin Lab Sci"},{"key":"ref89","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.jalz.2008.10.004","article-title":"Amyloid beta peptides in human plasma and tissues and their significance for Alzheimer\u2019s disease","volume":"5","author":"Roher","year":"2009","journal-title":"Alzheimers Dement"},{"key":"ref90","doi-asserted-by":"publisher","first-page":"35865","DOI":"10.1038\/srep35865","article-title":"Pre-amyloid oligomers budding: a metastatic mechanism of proteotoxicity","volume":"6","author":"Bernini","year":"2016","journal-title":"Sci Rep"},{"key":"ref91","doi-asserted-by":"publisher","first-page":"1294","DOI":"10.3390\/jpm11121294","article-title":"The potential of gamma secretase as a therapeutic target for cardiac diseases","volume":"11","author":"Sen","year":"2021","journal-title":"J Pers Med"},{"key":"ref92","doi-asserted-by":"publisher","first-page":"1932","DOI":"10.1055\/a-1914-2094","article-title":"Beta-Secretase-1 antisense rna is associated with vascular ageing and atherosclerotic cardiovascular disease","volume":"122","author":"Bampatsias","year":"2022","journal-title":"Thromb Haemost"},{"key":"ref93","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1007\/s10456-018-9653-2","article-title":"ADAM10 controls the differentiation of the coronary arterial endothelium","volume":"22","author":"Farber","year":"2019","journal-title":"Angiogenesis"},{"key":"ref94","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.3390\/jcm13041117","article-title":"Correlation of plasmatic amyloid Beta peptides (A\u03b2-40, A\u03b2-42) with myocardial injury and inflammatory biomarkers in acute coronary syndrome","volume":"13","author":"Del","year":"2024","journal-title":"J Clin Med"},{"key":"ref95","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1002\/prca.201200135","article-title":"Soluble amyloid precursor protein 770 is a novel biomarker candidate for acute coronary syndrome","volume":"7","author":"Kitazume","year":"2013","journal-title":"J Biol Chem"},{"key":"ref96","doi-asserted-by":"publisher","first-page":"e90523","DOI":"10.1371\/journal.pone.0090523","article-title":"Blood platelets in the progression of Alzheimer\u2019s disease","volume":"9","author":"Gowert","year":"2014","journal-title":"PLoS One"},{"key":"ref97","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1111\/jth.13209","article-title":"The Alzheimer\u2019s disease peptide \u03b2-amyloid promotes thrombin generation through activation of coagulation factor XII","volume":"14","author":"Zamolodchikov","year":"2016","journal-title":"J Thromb Haemost"},{"key":"ref98","doi-asserted-by":"publisher","first-page":"3872367","DOI":"10.1155\/2020\/3872367","article-title":"The role of matrix Metalloproteinase-9 in atherosclerotic plaque instability","volume":"2020","author":"Li","year":"2020","journal-title":"Mediat Inflamm"},{"key":"ref99","doi-asserted-by":"publisher","first-page":"373","DOI":"10.3390\/cells11030373","article-title":"Beta-amyloid instigates dysfunction of mitochondria in cardiac cells","volume":"11","author":"Jang","year":"2022","journal-title":"Cells"},{"key":"ref100","doi-asserted-by":"publisher","first-page":"100154","DOI":"10.1016\/j.rpth.2023.100154","article-title":"Human platelets release amyloid peptides \u03b2 and \u03b2 in response to haemostatic, immune, and hypoxic stimuli","volume":"7","author":"Wolska","year":"","journal-title":"Res Pract Thromb Haemost"},{"key":"ref101","doi-asserted-by":"publisher","first-page":"187","DOI":"10.3390\/biom10020187","article-title":"Circular RNA expression profiles in plasma from patients with heart failure related to platelet activity","volume":"10","author":"Sun","year":"2020","journal-title":"Biomol Ther"},{"key":"ref102","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1016\/j.jacc.2018.06.027","article-title":"Amyloid-beta (1-40) peptide and subclinical cardiovascular disease","volume":"72","author":"Stamatelopoulos","year":"2018","journal-title":"J Am Coll Cardiol"},{"key":"ref103","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1253\/circj.CJ-15-0872","article-title":"Elevated cardiac enzymes in hypertrophic cardiomyopathy patients with heart failure\u2013a 20-year prospective follow-up study\u2013","volume":"80","author":"Hamada","year":"2015","journal-title":"Circ J"},{"key":"ref104","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1186\/s13195-023-01174-0","article-title":"The dynamics of plasma biomarkers across the Alzheimer\u2019s continuum","volume":"15","author":"Guo","year":"2023","journal-title":"Alzheimers Res Ther"},{"key":"ref105","doi-asserted-by":"publisher","first-page":"93","DOI":"10.3389\/fnagi.2014.00093","article-title":"The low-density lipoprotein receptor-related protein 1 and amyloid-\u03b2 clearance in Alzheimer\u2019s disease","volume":"6","author":"Kanekiyo","year":"2014","journal-title":"Front Aging Neurosci"},{"key":"ref106","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1007\/s00401-016-1596-3","article-title":"Innate phagocytosis by peripheral blood monocytes is altered in Alzheimer\u2019s disease","volume":"132","author":"Gu","year":"2016","journal-title":"Acta Neuropathol"},{"key":"ref107","doi-asserted-by":"publisher","first-page":"1102809","DOI":"10.3389\/fnagi.2023.1102809","article-title":"Reconsidering the role of blood-brain barrier in Alzheimer\u2019s disease: from delivery to target","volume":"15","author":"Sousa","year":"2023","journal-title":"Front Aging Neurosci"},{"key":"ref108","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1111\/jnc.15096","article-title":"Receptor for advanced glycation end products up-regulation in cerebral endothelial cells mediates cerebrovascular-related amyloid \u03b2 accumulation after Porphyromonas gingivalis infection","volume":"158","author":"Zeng","year":"2021","journal-title":"J Neurochem"},{"key":"ref109","doi-asserted-by":"publisher","first-page":"1351","DOI":"10.1177\/002215540205001008","article-title":"Expression and localization of P-glycoprotein in human heart: effects of cardiomyopathy","volume":"50","author":"Meissner","year":"2002","journal-title":"J Histochem Cytochem"},{"key":"ref110","doi-asserted-by":"publisher","first-page":"125","DOI":"10.14218\/ERHM.2020.00062","article-title":"Pericytes and the neurovascular unit: the critical Nexus of Alzheimer disease pathogenesis?","author":"Cercy","year":"2021","journal-title":"Explor Res Hypothesis Med"},{"key":"ref111","doi-asserted-by":"publisher","first-page":"51","DOI":"10.3389\/fcvm.2019.00051","article-title":"Low density lipoprotein receptor-related protein-1 in cardiac inflammation and infarct healing","volume":"6","author":"Potere","year":"2019","journal-title":"Front Cardiovasc Med"},{"key":"ref112","doi-asserted-by":"publisher","first-page":"9655","DOI":"10.3390\/ijms21249655","article-title":"From brain to heart: possible role of amyloid-\u03b2 in ischemic heart disease and ischemia-reperfusion injury","volume":"21","author":"Gagno","year":"2020","journal-title":"Int J Mol Sci"},{"key":"ref113","doi-asserted-by":"publisher","first-page":"3087475","DOI":"10.1155\/2018\/3087475","article-title":"Neuroinflammatory cytokines induce amyloid beta neurotoxicity through modulating amyloid precursor protein levels\/metabolism","volume":"2018","author":"Alasmari","year":"2018","journal-title":"Biomed Res Int"},{"key":"ref114","doi-asserted-by":"publisher","first-page":"e18250","DOI":"10.1371\/journal.pone.0018250","article-title":"Calcium ions promote formation of amyloid \u03b2-peptide (1\u201340) oligomers causally implicated in neuronal toxicity of Alzheimer\u2019s disease","volume":"6","author":"Itkin","year":"2011","journal-title":"PLoS One"},{"key":"ref115","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1007\/s11897-012-0089-5","article-title":"Receptor for advanced glycation end products (RAGE) and implications for the pathophysiology of heart failure","volume":"9","author":"Ramasamy","year":"2012","journal-title":"Curr Heart Fail Rep"},{"key":"ref116","doi-asserted-by":"publisher","first-page":"e1901290","DOI":"10.1002\/mnfr.201901290","article-title":"Reduction in circulating advanced glycation end products by mediterranean diet is associated with increased likelihood of type 2 diabetes remission in patients with coronary heart disease: from the cordioprev study","volume":"65","author":"Gutierrez-Mariscal","year":"2021","journal-title":"Mol Nutr Food Res"},{"key":"ref117","doi-asserted-by":"publisher","first-page":"45897","DOI":"10.1074\/jbc.M407668200","article-title":"Systemic catabolism of Alzheimer\u2019s A\u03b240 and A\u03b242","volume":"279","author":"Ghiso","year":"2004","journal-title":"J Biol Chem"},{"key":"ref118","doi-asserted-by":"publisher","first-page":"6074","DOI":"10.1038\/s41380-021-01073-6","article-title":"Physiological clearance of amyloid-beta by the kidney and its therapeutic potential for Alzheimer\u2019s disease","volume":"26","author":"Tian","year":"2021","journal-title":"Mol Psychiatry"},{"key":"ref119","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1007\/s00401-015-1477-1","article-title":"Physiological amyloid-beta clearance in the periphery and its therapeutic potential for Alzheimer\u2019s disease","volume":"130","author":"Xiang","year":"2015","journal-title":"Acta Neuropathol"},{"key":"ref120","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1016\/j.jacc.2014.11.048","article-title":"Soluble neprilysin is predictive of cardiovascular death and heart failure hospitalization in heart failure patients","volume":"65","author":"Bay\u00e9s-Gen\u00eds","year":"2015","journal-title":"J Am Coll Cardiol"},{"key":"ref121","doi-asserted-by":"publisher","first-page":"187","DOI":"10.3389\/fnagi.2014.00187","article-title":"Amyloid-beta and Alzheimer\u2019s disease: the role of neprilysin-2 in amyloid-beta clearance","volume":"6","author":"Marr","year":"2014","journal-title":"Front Aging Neurosci"},{"key":"ref122","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1002\/iub.2203","article-title":"Albumin domain mutants with enhanced A\u03b2 binding capacity identified by phage display analysis for application in various peripheral A\u03b2 elimination approaches of Alzheimer\u2019s disease treatment","volume":"72","author":"Ishima","year":"2020","journal-title":"IUBMB Life"},{"key":"ref123","doi-asserted-by":"publisher","first-page":"880","DOI":"10.1038\/nm.3913","article-title":"Neutrophils promote Alzheimer\u2019s disease\u2013like pathology and cognitive decline via LFA-1 integrin","volume":"21","author":"Zenaro","year":"2015","journal-title":"Nat Med"},{"key":"ref124","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1186\/s12979-021-00236-x","article-title":"Hyperactivation of monocytes and macrophages in MCI patients contributes to the progression of Alzheimer\u2019s disease","volume":"18","author":"Munawara","year":"2021","journal-title":"Immun Ageing"},{"key":"ref125","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.jchf.2022.09.010","article-title":"Amyloid-\u03b2 and the risk of heart failure: cause or only association?","volume":"11","author":"Peikert","year":"2023","journal-title":"Heart Failure"},{"key":"ref126","doi-asserted-by":"publisher","first-page":"e24785","DOI":"10.1097\/MD.0000000000024785","article-title":"Prognostic role of albumin level in heart failure: a systematic review and meta-analysis","volume":"100","author":"El Iskandarani","year":"2021","journal-title":"Medicine (Baltimore)"},{"key":"ref127","doi-asserted-by":"publisher","first-page":"e0241003","DOI":"10.1371\/journal.pone.0241003","article-title":"Cardio-renal and cardio-hepatic interactions predict cardiovascular events in elderly patients with heart failure","volume":"15","author":"Okano","year":"2020","journal-title":"PLoS One"},{"key":"ref128","doi-asserted-by":"publisher","first-page":"1800","DOI":"10.1161\/HYPERTENSIONAHA.123.20598","article-title":"Functional and clinical importance of SGLT2-inhibitors in frailty: from the kidney to the heart","volume":"80","author":"Santulli","year":"2023","journal-title":"Hypertension"},{"key":"ref129","doi-asserted-by":"publisher","first-page":"9927533","DOI":"10.1155\/2021\/9927533","article-title":"The role of SGLT2 inhibitors in heart failure: a systematic review and Meta-analysis","volume":"2021","author":"Tsampasian","year":"2021","journal-title":"Cardiol Res Pract"},{"key":"ref130","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1186\/s40035-024-00431-y","article-title":"SGLT2 inhibitors: a novel therapy for cognitive impairment via multifaceted effects on the nervous system","volume":"13","author":"Mei","year":"2024","journal-title":"Transl Neurodegener"},{"key":"ref131","doi-asserted-by":"publisher","first-page":"811","DOI":"10.3390\/ijms25168811","article-title":"Effects of SGLT2-inhibitors on comprehensive geriatric assessment, biomarkers of oxidative stress, and platelet activation in elderly diabetic patients with heart failure with preserved ejection fraction","volume":"25","author":"Magurno","year":"2024","journal-title":"Int J Mol Sci"},{"key":"ref132","doi-asserted-by":"publisher","first-page":"1247","DOI":"10.2337\/dc21-2434","article-title":"Empagliflozin improves cognitive impairment in frail older adults with type 2 diabetes and heart failure with preserved ejection fraction","volume":"45","author":"Mone","year":"2022","journal-title":"Diabetes Care"},{"key":"ref133","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1007\/s40266-024-01153-6","article-title":"Differences in pharmacological treatment of heart failure among persons with or without major cognitive disorder: a cross-sectional study based on National Registries in Sweden","volume":"41","author":"Rankin","year":"2024","journal-title":"Drugs Aging"},{"key":"ref134","doi-asserted-by":"publisher","first-page":"1750","DOI":"10.3390\/biomedicines12081750","article-title":"Impact of sodium glucose cotransporter 2 inhibitors (SGLT2i) therapy on dementia and cognitive decline","volume":"12","author":"Lardaro","year":"2024","journal-title":"Biomedicines"}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2025.1494101\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,4]],"date-time":"2025-02-04T06:35:00Z","timestamp":1738650900000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2025.1494101\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,4]]},"references-count":134,"alternative-id":["10.3389\/fmed.2025.1494101"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2025.1494101","relation":{},"ISSN":["2296-858X"],"issn-type":[{"value":"2296-858X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,4]]},"article-number":"1494101"}}